Upper Extremity Deep Vein Thrombosis
Fig. 27.1 Deep veins that may be involved in upper extremity deep vein thrombosis (SVC, superior vena cava) In the absence of direct evidence, current treatment recommendations are largely extrapolated…
Cosmetic Approach to Varicose Veins: The ASVAL Technique
Fig. 14.1 Theory of anterograde evolution of the superficial venous insufficiency from the tributaries up to the saphenofemoral junction. The reflux starts in the tributaries (a). The saphenous vein is…
Anticoagulation for Proximal Deep Vein Thrombosis
Strong risk factors •Recent surgery •Recent trauma or fracture •Immobilization/bedbound >1 week Minor risk factors •Estrogen therapy •Pregnancy or within 3 months postpartum •Prolonged travel Adapted using information from [30, 49, 103]…
Clinical Presentation of Venous Insufficiency
Fig. 6.1 Telangiectasias /spider veins affecting the posterior calf Telangiectasias are a confluence of dilated intradermal venules less than 1 mm in caliber. Synonyms include spider veins, hyphen webs, and…
Diagnostic Imaging for Veins
Fig. 3.1 Noncompressible, dilated echolucent internal jugular vein seen in the transverse plane suggests acute thrombosis of the upper extremity (A) versus characteristics such as partial compressibility and bright echogenicity…
Presentation and Significance of Venous Thromboembolism
Fig. 19.1 Annual incidence of venous thromboembolism by age and sex VTE lends to significant morbidity and mortality within our society. The survival following VTE is significantly worse than the…
Endovenous Sealing of Superficial Veins
Fig. 11.1 The VenaSeal™ closure system VariClose® Vein Sealing System The VariClose® vein sealing system is similar to the VenaSeal™ closure system but uses a cyanoacrylate with a faster polymerisation…
Superficial Thrombophlebitis
Fig. 22.1 Algorithm for treatment of SVT Although proximal thigh GSV SVT and SSV SVT approaching the popliteal vein occurs not infrequently, the best treatment regimen based on its underlying…
Overview of Anticoagulation Agents
Fig. 21.1 Schematic view of the coagulation cascade and different targets of anticoagulant agents. Direct inhibitors specifically inhibit activated target coagulation factors (red and blue arrows), while traditional anticoagulants affect…
Prevention of Venous Thromboembolism
Fig. 20.1 Decision process of thromboprophylaxis in hospitalized patients. 1. At admission, each hospitalized patient must have an assessment of his/her risks of VTE and bleeding according to the clinical…
